Johnson & Johnson's new regional "innovation centres" will expand on the company's success with the US Janssen Labs project that opened earlier this year in San Diego to assist life science startups and connect the pharmaceutical company to promising new therapeutics, medical devices and consumer healthcare products (scripintelligence.com, 20 January 2012).
J&J announced on 18 September that it will establish four innovation centres in California (in San Francisco with a San Diego office), Boston, London, UK (covering Europe) and China (at a site to be decided) within the coming months to "accelerate early innovation and
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?